Table 1.
Initial body weight | Final body weight | % body weight change | Liver weight | Relative liver weight | |
---|---|---|---|---|---|
Control | 22.17 ± 0.70 | 24.23 ± 0.99* | 9.26 ± 1.18 ▲ | 4.37 ± 0.21 | 18.04 ± 0.13 |
CCl4 | 21.10 ± 0.34 | 17.49 ± 0.27*** | 17.07 ± 2.56 ▼ | 5.32 ± 0.18** | 32.53 ± 3.03 |
Silymarin | 21.64 ± 0.19 | 23.43 ± 0.25*** | 8.29 ± 1.39 ▲ | 4.30 ± 0.09NS | 18.37 ± 0.22 |
NOSE low | 21.71 ± 0.49 | 22.36 ± 0.67NS | 3.96 ± 3.90 ▲ | 4.59 ± 0.16NS | 20.56 ± 1.36 |
NOSE high | 22.25 ± 0.38 | 22.67 ± 0.18NS | 1.89 ± 2.38 ▲ | 4.55 ± 0.29NS | 20.05 ± 1.18 |
NORE low | 22.14 ± 0.38 | 22.59 ± 0.21NS | 2.25 ± 2.02 ▲ | 4.41 ± 0.16NS | 19.50 ± 0.58 |
NORE high | 22.20 ± 0.57 | 22.33 ± 0.46NS | 1.48 ± 0.26 ▲ | 4.24 ± 0.10NS | 19.00 ± 0.52 |
NS p > 0.05, *p < 0.05, **p < 0.01 and ***p < 0.001. Final body weight was compared with initial body weight of corresponding group and liver weight of treated groups were compared with liver weight of control group. ▲ represents increase and ▼ represents decrease